Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Vaxxinova US is seeking a Financial Analyst to join the finance team in Worthington, MN. The role involves partnering with various business functions, building Power BI dashboards, and supporting budgeting and forecasting. Strong cost accounting knowledge and ERP experience are required.
The position offers a day-shift schedule, with potential overtime based on production needs. Competitive benefits and growth opportunities are provided within a collaborative culture.
If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.
Finance Full Time Worthington, MN, US
30+ days ago Requisition ID: 1200
Salary Range: $70,000.00 To $105,000.00 Annually
Vaxxinova US is seeking an individual to join our finance team as a Financial Analyst in Willmar or Worthington, Minnesota.
At Vaxxinova US, you’ll be part of a passionate team dedicated to making a difference. We offer competitive pay and benefits, opportunities for growth, and a supportive work culture.
The Financial Analyst will work closely with all areas of the business and act as a Business Partner. They will help bring visibility to the business through the creation of models and dashboards while also assisting in the creation of the budget.
We are proud to offer a generous benefit package in addition to competitive compensation, including employer contributions towards medical, dental and vision premiums. Most benefits begin on date of hire. Our benefits include:
Vaxxinova provides a wide range of both autogenous and licensed vaccines combined with high-level diagnostic services, supported by strong R&D. Our focus is on livestock including cattle, poultry, swine and aqua. Vaxxinova US, formerly known as Epitopix and Newport Laboratories, is the US operating unit of Vaxxinova International, headquartered in the Netherlands. Vaxxinova US has a strong market presence making autogenous vaccines for cattle, swine, and poultry as well as a state-of-the‑art diagnostic laboratory. Vaxxinova currently has facilities in fourteen countries including Brazil, Canada, Chile, Colombia, Croatia, Italy, Germany, Japan, Jordan, Norway, South Africa, Thailand, the USA, and the Netherlands. Vaxxinova is part of the family‑owned EW Group, headquartered in Germany. The EW Group specializes in animal genetics, animal nutrition and animal health, operates in over 100 countries and records consistent international growth.